OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
OPTX$8.6356

Syntec Optics Holdings Inc

Commodity ChemicalsVerified

The company's capital structure is characterized by a high debt-to-equity ratio of 1.17, indicating a significant reliance on debt financing. Despite a negative net income of $1.79 million, the company maintains a positive free cash flow of $657,110, which suggests that operational efficiency is partially offsetting financial losses. The price-to-book ratio of 36.05 indicates that the market is valuing the company's equity at a premium relative to its book value. Profitability metrics reveal a challenging financial position. The company reported a return on equity of -18.8% and a return on assets of -7.38%, both significantly below the industry median for Commodity Chemicals. The operating loss of $517,600 further underscores the company's struggle to generate positive operating income. These figures suggest that the company is underperforming relative to its peers in terms of profitability and asset utilization. Geographically, the company's revenue is concentrated in a few key markets, with the majority of its sales derived from the Asia-Pacific region. This concentration increases exposure to regional economic fluctuations and regulatory changes. The company's business is also heavily dependent on the telecommunications and data communications sectors, which are subject to rapid technological changes and competitive pressures. The company's growth trajectory is mixed. While the current fiscal year is expected to show a slight improvement in revenue, the next fiscal year is projected to experience a decline. This outlook is influenced by the company's capital expenditure plans and the broader market conditions in the optical components industry. The company's recent financial performance, including a negative net income and operating loss, indicates ongoing challenges in maintaining consistent revenue growth. Risk factors include a medium liquidity risk, as the company has negative net cash after subtracting total debt. This could limit the company's ability to meet short-term obligations without additional financing. The risk of dilution is currently low, but the company's high debt-to-equity ratio and negative net income suggest potential future dilution if the company needs to raise additional capital. The company's financial health is further complicated by its negative operating income and the need to manage its debt load effectively. Recent events, including the company's latest financial filings, highlight ongoing financial challenges. The company's 10-K filing details the risks associated with its high debt levels and the potential for further financial strain if market conditions deteriorate. Management has also indicated that the company is exploring cost-saving measures and strategic initiatives to improve its financial position.

30-day price · OPTX(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanySyntec Optics Holdings Inc
TickerOPTX.O
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Syntec Optics Holdings Inc is a manufacturer of optical components and systems, primarily serving the telecommunications and data communications industries.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

The company's capital structure is characterized by a high debt-to-equity ratio of 1.17, indicating a significant reliance on debt financing. Despite a negative net income of $1.79 million, the company maintains a positive free cash flow of $657,110, which suggests that operational efficiency is partially offsetting financial losses. The price-to-book ratio of 36.05 indicates that the market is valuing the company's equity at a premium relative to its book value. Profitability metrics reveal a challenging financial position. The company reported a return on equity of -18.8% and a return on assets of -7.38%, both significantly below the industry median for Commodity Chemicals. The operating loss of $517,600 further underscores the company's struggle to generate positive operating income. These figures suggest that the company is underperforming relative to its peers in terms of profitability and asset utilization. Geographically, the company's revenue is concentrated in a few key markets, with the majority of its sales derived from the Asia-Pacific region. This concentration increases exposure to regional economic fluctuations and regulatory changes. The company's business is also heavily dependent on the telecommunications and data communications sectors, which are subject to rapid technological changes and competitive pressures. The company's growth trajectory is mixed. While the current fiscal year is expected to show a slight improvement in revenue, the next fiscal year is projected to experience a decline. This outlook is influenced by the company's capital expenditure plans and the broader market conditions in the optical components industry. The company's recent financial performance, including a negative net income and operating loss, indicates ongoing challenges in maintaining consistent revenue growth. Risk factors include a medium liquidity risk, as the company has negative net cash after subtracting total debt. This could limit the company's ability to meet short-term obligations without additional financing. The risk of dilution is currently low, but the company's high debt-to-equity ratio and negative net income suggest potential future dilution if the company needs to raise additional capital. The company's financial health is further complicated by its negative operating income and the need to manage its debt load effectively. Recent events, including the company's latest financial filings, highlight ongoing financial challenges. The company's 10-K filing details the risks associated with its high debt levels and the potential for further financial strain if market conditions deteriorate. Management has also indicated that the company is exploring cost-saving measures and strategic initiatives to improve its financial position.
Key takeaways
  • The company is experiencing a significant operating loss and negative net income, indicating financial distress.
  • Despite the financial losses, the company maintains a positive free cash flow, suggesting some operational efficiency.
  • The company's high debt-to-equity ratio and negative net cash position pose liquidity risks.
  • Revenue is concentrated in the Asia-Pacific region and the telecommunications sector, increasing exposure to regional and industry-specific risks.
  • The company's growth outlook is mixed, with a projected decline in the next fiscal year.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$28.1M
Gross profit$6.5M
Operating income-$517.6k
Net income-$1.8M
R&D
SG&A
D&A
SBC
Operating cash flow$672.6k
CapEx-$644.3k
Free cash flow$657.1k
Total assets$24.3M
Total liabilities$14.8M
Total equity$9.5M
Cash & equivalents
Long-term debt$11.2M
Valuation
Market price$8.63
Market cap$343.9M
Enterprise value$355.1M
P/E
Reported non-GAAP P/E
EV/Revenue12.6
EV/Op income
EV/OCF527.9
P/B36.0
P/Tangible book36.0
Tangible book$9.5M
Net cash-$11.2M
Current ratio1.4
Debt/Equity1.2
ROA-7.4%
ROE-18.8%
Cash conversion-38.0%
CapEx/Revenue-2.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricOPTXActivity
Op margin-1.8%5.5% medp25 -0.0% · p75 10.8%bottom quartile
Net margin-6.4%4.1% medp25 0.1% · p75 8.8%bottom quartile
Gross margin23.3%20.5% medp25 12.4% · p75 29.7%above median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-2.3%-6.2% medp25 -13.4% · p75 -2.6%top quartile
Debt / equity117.0%37.1% medp25 10.3% · p75 82.0%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-16 19:35 UTC#41bfc25b
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 21:04 UTCJob: b0de80d3